Javier Castro-Garcia - Publications

Celyvir: Oncolytic Virotherapy with Mesenchymal Stromal Cells. From Concept to Clinical Translation.

Journal: Human gene therapy

Published: July 16, 2026

Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapy.

Journal: Experimental hematology & oncology

Published: January 14, 2026

Unaltered NKG2D-CAR T cell function under hypoxia in osteosarcoma in vitro.

Journal: Cancer immunology, immunotherapy : CII

Published: August 21, 2025

Efficiency of ultrasound-guided placental gene therapy in a rabbit IUGR model and effects on offspring development.

Journal: Frontiers in veterinary science

Published: May 22, 2025

A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 20, 2024

LIN28 upregulation in primary human T cells impaired CAR T antitumoral activity.

Journal: Frontiers in immunology

Published: July 10, 2024

Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy.

Journal: Molecular therapy. Oncology

Published: April 18, 2024

Systemic cellular viroimmunotherapy for canine high-grade gliomas.

Journal: Journal for immunotherapy of cancer

Published: October 19, 2022

Switchable CAR T cell strategy against osteosarcoma.

Journal: Cancer immunology, immunotherapy : CII

Published: October 11, 2022

Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing.

Journal: Cancer research communications

Published: September 13, 2022

Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide Treatment.

Journal: Frontiers in cell and developmental biology

Published: December 14, 2021

Systemic Treatment of Immune-Mediated Keratoconjunctivitis Sicca with Allogeneic Stem Cells Improves the Schirmer Tear Test Score in a Canine Spontaneous Model of Disease.

Journal: Journal of clinical medicine

Published: November 07, 2021